174 related articles for article (PubMed ID: 38586213)
1. Ketogenic metabolic therapy in conjunction with standard treatment for glioblastoma: A case report.
Phillips MCL; Thotathil Z; Dass PH; Ziad F; Moon BG
Oncol Lett; 2024 May; 27(5):230. PubMed ID: 38586213
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of
Seyfried TN; Shivane AG; Kalamian M; Maroon JC; Mukherjee P; Zuccoli G
Front Nutr; 2021; 8():682243. PubMed ID: 34136522
[No Abstract] [Full Text] [Related]
3. Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series.
Phillips MCL; Leyden J; McManus EJ; Lowyim DG; Ziad F; Moon BG; Haji Mohd Yasin NAB; Tan A; Thotathil Z; Jameson MB
J Oncol; 2022; 2022():4496734. PubMed ID: 36276276
[TBL] [Abstract][Full Text] [Related]
4. Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.
Elsakka AMA; Bary MA; Abdelzaher E; Elnaggar M; Kalamian M; Mukherjee P; Seyfried TN
Front Nutr; 2018; 5():20. PubMed ID: 29651419
[TBL] [Abstract][Full Text] [Related]
5. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
Seyfried TN; Shelton L; Arismendi-Morillo G; Kalamian M; Elsakka A; Maroon J; Mukherjee P
Neurochem Res; 2019 Oct; 44(10):2392-2404. PubMed ID: 31025151
[TBL] [Abstract][Full Text] [Related]
6. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.
Zuccoli G; Marcello N; Pisanello A; Servadei F; Vaccaro S; Mukherjee P; Seyfried TN
Nutr Metab (Lond); 2010 Apr; 7():33. PubMed ID: 20412570
[TBL] [Abstract][Full Text] [Related]
7. Role of ketogenic metabolic therapy in malignant glioma: A systematic review.
Winter SF; Loebel F; Dietrich J
Crit Rev Oncol Hematol; 2017 Apr; 112():41-58. PubMed ID: 28325264
[TBL] [Abstract][Full Text] [Related]
8. Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study.
Martin-McGill KJ; Marson AG; Tudur Smith C; Jenkinson MD
Pilot Feasibility Stud; 2017; 3():67. PubMed ID: 29209515
[TBL] [Abstract][Full Text] [Related]
9. Complete remission of depression and anxiety using a ketogenic diet: case series.
Calabrese L; Frase R; Ghaloo M
Front Nutr; 2024; 11():1396685. PubMed ID: 38887496
[TBL] [Abstract][Full Text] [Related]
10. Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement.
Klein P; Tyrlikova I; Zuccoli G; Tyrlik A; Maroon JC
Cancer Metab; 2020 Nov; 8(1):24. PubMed ID: 33292598
[TBL] [Abstract][Full Text] [Related]
11. The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer.
Meidenbauer JJ; Mukherjee P; Seyfried TN
Nutr Metab (Lond); 2015; 12():12. PubMed ID: 25798181
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Feasibility and Effects of a Ketogenic Diet in Patients With CNS Malignancies: A Retrospective Case Series.
Panhans CM; Gresham G; Amaral LJ; Hu J
Front Neurosci; 2020; 14():390. PubMed ID: 32508561
[No Abstract] [Full Text] [Related]
13. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
Ene CI; Cimino PJ; Fine HA; Holland EC
Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
[TBL] [Abstract][Full Text] [Related]
14. Managing Metastatic Thymoma With Metabolic and Medical Therapy: A Case Report.
Phillips MCL; Murtagh DKJ; Sinha SK; Moon BG
Front Oncol; 2020; 10():578. PubMed ID: 32457832
[TBL] [Abstract][Full Text] [Related]
15. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.
Champ CE; Palmer JD; Volek JS; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Shi W
J Neurooncol; 2014 Mar; 117(1):125-31. PubMed ID: 24442482
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
McBain C; Lawrie TA; Rogozińska E; Kernohan A; Robinson T; Jefferies S
Cochrane Database Syst Rev; 2021 May; 5(1):CD013579. PubMed ID: 34559423
[TBL] [Abstract][Full Text] [Related]
17. Ketogenic metabolic therapy for chronic kidney disease - the pro part.
Weimbs T; Saville J; Kalantar-Zadeh K
Clin Kidney J; 2024 Jan; 17(1):sfad273. PubMed ID: 38186906
[TBL] [Abstract][Full Text] [Related]
18. Case report: Resolution of malignant canine mast cell tumor using ketogenic metabolic therapy alone.
Seyfried TN; Mukherjee P; Lee DC; Ta L; Nations L
Front Nutr; 2023; 10():1157517. PubMed ID: 37057065
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.
Rapp M; Grauer OM; Kamp M; Sevens N; Zotz N; Sabel M; Sorg RV
Trials; 2018 May; 19(1):293. PubMed ID: 29801515
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.
Lukács G; Tóth Z; Sipos D; Csima M; Hadjiev J; Bajzik G; Cselik Z; Semjén D; Repa I; Kovács Á
Ideggyogy Sz; 2018 Mar; 71(3-04):95-103. PubMed ID: 29889468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
